Original scientific articleThe potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial☆☆☆-Science-Chemical Encyclopedia-lookchem

Original scientific articleThe potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial☆☆☆
Add time:08/14/2019 Source:sciencedirect.com

BackgroundPancreatectomy can be complicated by pancreatic anastomotic leakage, causing major morbidity.

We also recommend Trading Suppliers and Manufacturers of Vapreotide Acetate (cas 116430-60-5). Pls Click Website Link as below: cas 116430-60-5 suppliers

Prev:Self-assembly synthesis of vapreotide‑gold hybrid nanoflower for photothermal antitumor activity
Next: PaperEffect of κ-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig)

Click to view details

Health and Chemicalmore >